Search Orphan Drug Designations and Approvals
-
Generic Name: | A small molecule inhibitor of the pro-survival protein Myeloid Cell Leukemia sequence 1 (MCL 1) |
---|---|
Date Designated: | 02/15/2019 |
Orphan Designation: | Treatment of Acute Myeloid Leukemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Amgen Inc. One Amgen Center Drive Mail Stop 27-2-D Thousand Oaks, California 91320-1799 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-